Pancreatic Cancer Research

ResearcherUniversity of Kansas Medical CenterNo recent work listed

Chandrayee Ghosh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2336-8487; OpenAlex author ID A5101767264. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

  1. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Co-author DOI 10.1053/j.gastro.2019.11.279↗
  2. Super-enhancers: novel target for pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.26704↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Prasad R. Dandawate · 2 shared papers, 2019–2020 · strength 0.18
  2. Dharmalingam Subramaniam · 2 shared papers, 2019–2020 · strength 0.18
  3. Shrikant Anant · 2 shared papers, 2019–2020 · strength 0.18
  4. Animesh Dhar · 2 shared papers, 2019–2020 · strength 0.18
  5. Weijing Sun · 1 shared paper, 2020 · strength 0.08
  6. Domenico Coppola · 1 shared paper, 2020 · strength 0.08
  7. Subhash Padhyé · 1 shared paper, 2020 · strength 0.08
  8. Mokenge Peter Malafa · 1 shared paper, 2020 · strength 0.08
  9. Anup Kasi · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.